COMMUNIQUÉS West-GlobeNewswire

-
VistaGen Therapeutics Issued Two Key U.S. Patents for Treatment of Depression with AV-101
13/06/2018 -
Cutera Announces Expansion of FDA Indications for the truSculpt® Body Contouring System
13/06/2018 -
Avinger Appoints Mark Weinswig as Chief Financial Officer
13/06/2018 -
Stealth Mark Receives Letter of Intent (LOI) from ICTA
13/06/2018 -
Telefónica Showcasing GPS SmartSole and BioStride at CeBIT 2018
13/06/2018 -
BioTel Care, a BioTelemetry Company, Announces Release of Next-Generation Wireless Blood Glucose Monitor
13/06/2018 -
Summit Medical Group to Implement Altura’s Novel HCP Studies™ Mobile Platform to Support Expanding Patient Access to Clinical Studies
13/06/2018 -
Novan to Participate in Upcoming Investor Conferences
13/06/2018 -
Catalyst Pharmaceuticals Appoints Daniel J. Brennan as Chief Commercial Officer
13/06/2018 -
Voted as One of the Best, Richmond Plastic Surgeon Earns Series of Awards
13/06/2018 -
Actinium Pharmaceuticals Announces Treatment of First Patient in Novel Combination Trial of Actimab-A Plus CLAG-M
13/06/2018 -
CLS Holdings USA Awarded Non-Provisional U.S. Utility Patent for Cannabidiol Extraction and Conversion Process
13/06/2018 -
UroGen Pharma’s Chairman, Arie Belldegrun, MD, FACS to Receive EY 2018 Master Entrepreneur Award
13/06/2018 -
TRACON Announces Presentation of Preclinical Data from Studies of TRC105 in Combination with a PD-1 Antibody in Murine Models of Colorectal Cancer
13/06/2018 -
Savara to Present at JMP Securities 2018 Life Sciences Conference on June 20th
13/06/2018 -
scPharmaceuticals Receives Complete Response Letter from the FDA for FUROSCIX®
13/06/2018 -
Atara Biotherapeutics Announces Publication of New Research Linking Epstein-Barr Virus (EBV) Infection and Multiple Sclerosis (MS)
13/06/2018 -
Immunomedics Announces Pricing of Public Offering of Common Stock
13/06/2018 -
Tetra Bio-Pharma Inc. Provides Corporate Update Ahead of Its Annual General Meeting
13/06/2018
Pages